Leading a Culture of Innovation
Practices
Diligence is the Hallmark of Our Services
Recent News
Read written Recent News About IP and Technology
GlobeNewswire
2025
FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received seven years of orphan-drug exclusive approval from U.S. Food and Drug A…...
Read MoreGlobeNewswire
2025
FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the third quarter of 2025 Preparations for Phase 1/2 clinical trial …...
Read MoreGlobeNewswire
2025
Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results
FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the period…...
Read MoreIPWatchdog.com
2025
Another Director Review Request Demonstrates Extent of PTAB Hubris
Last week, yet another request for Director Review shined a light on what has become the seedy underbelly of the Patent Trial and Appeal Board (PTAB). In Innoscience Technology Co. LTD., v. Efficient Power Conversion Corp. (IPR2023-01381), not only did the PT…...
Read More
GlobeNewswire
2025
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
Agios Pharmaceuticals will be featured in oral and poster presentations during the 30th European Hematology Association Congress on June 12-15, 2025..........
Read MorePlos.org
2025
The comparative effectiveness and safety of fluticasone-salmeterol via metered-dose versus dry powder inhalers for COPD: A new user cohort study
Author summary Why was this study done? Little real-world evidence exists comparing the effectiveness and safety of metered-dose versus dry powder inhalers for patients with chronic obstructive pulmonary disease (COPD) treated in routine clinical care. H…...
Read MoreOur Insights
Insight, Story & Blog
Artificial Intelligence Key Legal Issues: Overview
Read More
Running a Law Firm on Open Source Technology: Embracing Efficiency and Cost-Effectiveness
Read More
Evaluating and Assessing a Civil Lawsuit
Read More
Corporate Structuring and Running Multiple Businesses: A Deep Dive into Holding, Operating, and Parent Companies
Read More
The Art of Defending Depositions in Federal Court: A Comprehensive Guide
Read MoreGet in Touch
Ready to work
together? Let's go!
MC Law loves hearing from you. Send us a message to inquire how we can solve your legal issues.
Phone: +1 202.409.1003
Email: contact@mclaw.io
Professionals
OFFICES
PROFESSIONALS
OFFICES
